Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about MRK

Recent news which mentions MRK

...

26 27 28 29 30 31 32 33 Next >

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO

October 01, 2021

Here’s where to hunt for yield, according to a Fidelity fund manager

October 01, 2021

Merck COVID-19 Oral Antiviral Cuts Risk of Hospitalization, Death By 50%

October 01, 2021

GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact

September 30, 2021

Merck, Sutro Biopharma Extends Cytokine Derivative Research Program

September 30, 2021

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug

September 30, 2021

Merck Seals Acceleron Pharma Deal For $180/Share: Highlights

September 30, 2021

A Peek Into The Markets: US Stock Futures Climb Ahead Of GDP, Jobless Claims Data

September 30, 2021

Merck's COVID-19 Antiviral Pill Effective Against Variants, Lab Studies Show

September 29, 2021

7 Biotech Stocks Entering the Golden Boom Phase

September 28, 2021

Only 47 stocks in the S&P 500 have fallen over the past year — Wall Street predicts they will climb up to 54% in 12 months

September 28, 2021

Why Are I-Mab Shares Trading Higher On Tuesday?

September 28, 2021

The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive

September 28, 2021

These sectors are looking so cheap that ESG considerations will have to be put on standby, strategist says

September 28, 2021

Merck Reportedly Lead Bidder In $11B Acceleron Buyout: WSJ

September 28, 2021

A Peek Into The Markets: US Stock Futures Down Ahead Of Economic Data, Fed Speakers

September 28, 2021

Moderna CEO Predicts Pandemic Could End in 2022: Here's Why the Stock Could Plunge If He's Right

September 28, 2021

5 Stocks To Watch For September 28, 2021

September 28, 2021

Merck nears deal for rare-disease-drug maker Acceleron

September 28, 2021

Pfizer Begins Late-Stage Study To Test Effectiveness Of Oral Drug Against COVID-19 In Those Exposed To The Virus

September 28, 2021

Merck's Keytruda Tops Placebo On Overall Survival Endpoint In Liver Cancer Patients

September 27, 2021

Acceleron In Advanced $11B Buyout Talks: Bloomberg

September 27, 2021

Why AstraZeneca Stock Is Trading Higher Today

September 24, 2021

AstraZeneca - Merck's Lynparza Delays Disease Progression In Prostate Cancer Patients

September 24, 2021

9 Health Care Stocks Showing Unusual Options Activity In Today's Session

September 21, 2021

These 3 Dow Stocks Are Set to Soar in 2021's Second Half and Beyond

September 21, 2021

Apple And Disney Lead The Dow Jones Lower

September 20, 2021

Here are the worst-performing U.S. stocks as the Evergrande crisis rattles investors

September 20, 2021

Merck Backs Up Keytruda Approval In TNBC With Encouraging Overall Survival Data

September 20, 2021

Seagen, Genmab Present Tisotumab Vedotin Combo Data In Cervical Cancer

September 20, 2021

...

26 27 28 29 30 31 32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.